1. Home
  2. > Healthcare Market Trends
Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and End User

Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and End User

  • July 2022
  • 170 pages
  • ID: 6316320
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The blood irradiation market is projected to reach US$ 104.37 million by 2028 from US$ 65.15 million in 2021; it is expected to grow at a CAGR of 7.0% from 2022 to 2028.

The increase in communicable and noncommunicable diseases prevalence and rise in healthcare expenditure and government initiatives are among the factors driving the market growth.There is an increase in the number of incidence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, owing to a large population across the world susceptible to such conditions.

According to World Health Organization (WHO), cardiovascular disorders are the leading cause of death globally, and ~17.9 million deaths are reported yearly. Additionally, the rising prevalence of communicable diseases, such as Hepatitis, influenza, Human Immunodeficiency Virus (HIV), and acquired immunodeficiency syndrome (AIDS), are driving the growth of the blood irradiation market. According to WHO, 325 million people were infected with the hepatitis B virus in 2020, and 900,000 people die from hepatitis B virus infection every year. Moreover, a large geriatric population across the world is contributing to the prevalence of noncommunicable diseases, such as cardiovascular disorders, renal disorders, and strokes. According to WHO, the population of people aged 60 years and above was 1 billion in 2019 and is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. The elderly population is susceptible to noncommunicable disease conditions owing to various factors such as poor nutrition, lack of physical activity, excessive use of tobacco, and consumption of alcohol.
Additionally, surging blood transfusion owing to an increase in surgical procedures, accidents, trauma cases, and disorders, along with the rising prevalence of bloodstream infections, supports the market growth.Bloodstream infections, underlying conditions, and invasive procedures are common among the geriatric population.

Bloodstream infections are the major cause of illness and death among large populations.According to the National Library of Medicine, ~28,000 bloodstream infections occur across the world annually.

Moreover, rising awareness about bloodstream infections and increasing immune responses to transfused blood can cause complications as increasing use of irradiated blood in cancer treatment strengthens the immune system and improves overall health of patients, which is driving the growth of the blood irradiation market.

Thus, the increase in prevalence of communicable and noncommunicable disorders, rise in blood transfusion, surge in bloodstream infections, and increase in immune responses are driving the growth of the blood irradiation market.
Increasing immunocompromised population and rising leukemia and lymphoma cases are expected to create ample opportunities for the blood irradiation market in the coming years. According to American Medical Association, in 2021, around 2.7% of the US adult population, ~7 million people, were immunocompromised, due to organ transplants, cancer, and autoimmune disorders. As per the National Institute of Environmental Health Sciences, autoimmune disorders affected more than 24 million population in the US in 2021, and their prevalence rate ranges from 5 to 8%. Additionally, the rising prevalence of cancer and tumors increased the use of chemotherapy and other treatments that negatively affect an individual’s immune system. According to World Cancer Research Fund International, 18.1 million cancer cases were diagnosed in 2020, of which 9.3 million were men and 8.8 million were women.
Moreover, there has been significant growth in leukemia and lymphoma incidence rates across the world. According to Leukemia and Lymphoma Society, an estimated total of 186,400 people in the US were diagnosed with leukemia, lymphoma, or myeloma in 2021, and new cases of leukemia, lymphoma, and myeloma are accounted for 9.8% of the estimated 1,898,160 new cancer cases in 2021. Thus, a significant increase in the immunocompromised population and the rising prevalence of autoimmune disorders are expected to create ample opportunities for the blood irradiation market growth in the coming years.

Blood irradiators are a major requirement in the healthcare industry. Hence, researchers have been carrying out research & development activities, which have resulted in product innovations.
For instance, in November 2018, JW Bioscience, a subsidiary of JW Pharmaceutical, launched Sangray developed by Hitachi.Sangray is a medical device used to prevent transfusion-related graft-versus-host disease by irradiating a blood bag for transfusion with X-rays.

It is also Korea’s first blood radiation device that does not use Cesium-137, which is a hazardous radioactive substance.
There have been advancements in alternative technologies, such as proton and ion beam therapies, that use high-energy, positive ions and have high precision in treating tumors with reduced exposure to normal tissues.Moreover, FLASH radiotherapy, carbon ion therapy, volumetric-modulated arc therapy, and intensity-modulated radiotherapy treat solid tumors.

These technological advancements and developments have a high precision rate with reduced side effects, likely to create ample opportunities for the blood irradiation market in the coming years. Thus, an increase in technological advancements, rise in product launches, and the surge in the use of alternative technologies are expected to support the growth of the market in the coming years..
Further, rising partnerships and collaborations of blood centers and huge companies drive the growth of the blood irradiators market.
Geography-Based Insights
North America held the largest share of the blood irradiation market in 2021.The US held the largest market share in North America.

Advanced healthcare infrastructure, easy accessibility to medical facilities, and rising emphasis on improving treatment outcomes are expected to accelerate the growth of the market during the forecast period.
Asia Pacific is expected to witness the highest growth in the global blood irradiation market during the forecast period.In the coming years, the market is the region is expected to grow significantly in China, Japan, India, and other countries.

The market is driven by growing investments from international players in China and India, improving government support in countries such as China, and advancing healthcare infrastructure. Therefore, the region would hold huge potential for the blood irradiation market players to grow during the forecast period.
Type-Based Insights
The blood irradiation market, based on type, is segmented into intravenous laser blood irradiation , transcutaneous laser blood irradiation,and extracorporeal blood irradiation.In 2021, the intravenous laser blood irradiation segment accounted for the largest market share.

However, the extracorporeal laser blood irradiation segment is expected to register the highest CAGR of 7.8% during the forecast period.

End User-Based Insights
Based on end user, the blood irradiation market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes.The hospitals segment held the largest market share in 2021.

However, the blood banks segment is estimated to register the highest CAGR of 7.7% in the market during the forecast period.

Indication-Based Insights
By indication, the blood irradiation market is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others.The acute leukemia segment held the largest market share in 2021.

However, the lymphoma segment is estimated to register the highest CAGR of 8.8% in the market during the forecast period.
The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Eurostat are a few secondary sources referred to while preparing the report on the blood irradiation market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Oncology Devices Global Market Report 2023

  • $ 5000
  • February 2023
  • 250 pages

Major players in the oncology devices market are Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated, ...

  • World
  • APAC
  • Healthcare
  • Medical Device
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on